Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | Bexarotene | CTRPv2 | pan-cancer | AAC | 0.0077 | 0.8 |
mRNA | pitstop2 | CTRPv2 | pan-cancer | AAC | -0.0098 | 0.8 |
mRNA | tacrolimus | CTRPv2 | pan-cancer | AAC | 0.0074 | 0.8 |
mRNA | 3-Cl-AHPC | CTRPv2 | pan-cancer | AAC | 0.007 | 0.8 |
mRNA | lenalidomide | GDSC1000 | pan-cancer | AAC | -0.0073 | 0.8 |
mRNA | ouabain | CTRPv2 | pan-cancer | AAC | -0.0072 | 0.8 |
mRNA | XMD13-2 | GDSC1000 | pan-cancer | AAC | 0.0063 | 0.8 |
mRNA | NVP-ADW742 | CTRPv2 | pan-cancer | AAC | -0.0071 | 0.8 |
mRNA | WAY-362450 | CTRPv2 | pan-cancer | AAC | -0.0075 | 0.8 |
mRNA | EHT 1864 | GDSC1000 | pan-cancer | AAC | -0.0067 | 0.8 |